Search Results - "Tong, Xiuzhen"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patients by Zhang, Xuanye, Rao, Huilan, Xu, Xiaolu, Li, Zhihua, Liao, Bing, Wu, Hongmei, Li, Mei, Tong, Xiuzhen, Li, Juan, Cai, Qingqing

    Published in Cancer science (01-01-2018)
    “…Castleman disease (CD) is a rare lymphoproliferative disorder. To assess the clinical features, outcomes, and prognostic factors of this disease, we…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Independent oncogenic and therapeutic significance of phosphatase PRL‐3 in FLT3‐ITD–negative acute myeloid leukemia by Qu, Shuang, Liu, Bin, Guo, Xiaoling, Shi, Hongshun, Zhou, Meifeng, Li, Li, Yang, Shulan, Tong, Xiuzhen, Wang, Haihe

    Published in Cancer (15-07-2014)
    “…BACKGROUND Internal tandem duplication of FMS‐like tyrosine kinase (FLT3‐ITD) is well known to be involved in acute myeloid leukemia (AML) progression, but…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Histone methylation modification patterns and relevant M-RiskScore in acute myeloid leukemia by Rong, Dade, Chen, Xiaomin, Xiao, Jing, Liu, Daiyuan, Ni, Xiangna, Tong, Xiuzhen, Wang, Haihe

    Published in Heliyon (01-09-2022)
    “…We tried to identify novel molecular subtypes of acute myeloid leukemia (AML) associated with histone methylation and established a relevant scoring system to…”
    Get full text
    Journal Article
  6. 6

    A favorable inductive remission rate for decitabine combined with chemotherapy as a first course in <60‐year‐old acute myeloid leukemia patients with myelodysplasia syndrome features by Liu, Fengqi, Wang, Hehua, Liu, Junru, Zhou, Zhenhai, Zheng, Dong, Huang, Beihui, Su, Chang, Zou, Waiyi, Xu, Duorong, Tong, Xiuzhen, Li, Juan

    Published in Cancer medicine (Malden, MA) (01-09-2019)
    “…In acute myeloid leukemia (AML), myelodysplasia‐related changes contribute to a poor prognosis. This retrospective, propensity score‐matched study analyzed 108…”
    Get full text
    Journal Article
  7. 7

    Comparing five diagnostic criteria for multiple myeloma: a retrospective study of 227 cases by Junxun, Li, Juan, Li, Xiuzhen, Tong, Juan, Ouyang, Bohuang, Zeng, Junru, Liu

    Published in Tumori (01-03-2014)
    “…AIMS AND BACKGROUNDSeveral diagnostic criteria for multiple myeloma are used in clinical practice, and it can be difficult to reach a diagnosis when a…”
    Get full text
    Journal Article
  8. 8

    Comparing Five Diagnostic Criteria for Multiple Myeloma: A Retrospective Study of 227 Cases by Junxun, Li, Juan, Li, Xiuzhen, Tong, Juan, Ouyang, Bohuang, Zeng, Junru, Liu

    Published in Tumori (01-03-2014)
    “…Aims and Background Several diagnostic criteria for multiple myeloma are used in clinical practice, and it can be difficult to reach a diagnosis when a…”
    Get full text
    Journal Article
  9. 9

    Blastoid mantle cell lymphoma involving skin and orbit with hypercalcemia: A case report and literature review by Juan Li, Han Ma, Xiuzhen Tong, Chang Su, Dong Zheng, Mei Chen, Chun Lu

    Published in Zhonghua pi fu ke yi xue za zhi (01-06-2013)
    “…Mantel cell lymphoma is one of the small B-cell non-Hodgkin's lymphomas and usually involves lymph nodes, bone marrow, spleen, liver, gastrointestinal tract,…”
    Get full text
    Journal Article
  10. 10

    Downregulated Poly-C binding protein-1 is a novel predictor associated with poor prognosis in Acute Myeloid Leukemia by Zhou, Meifeng, Tong, Xiuzhen

    Published in Diagnostic pathology (21-08-2015)
    “…Depletion of Poly-C binding protein-1(PCBP1) is implicated in various human malignancies. However, the underlying biological effect of PCBP1 in cancers,…”
    Get full text
    Journal Article
  11. 11

    Role of Measurable Residual Disease in Older Adult Acute Myeloid Leukemia by Li, Xueyao, Tong, Xiuzhen

    Published in Clinical interventions in aging (01-01-2023)
    “…There is overwhelming evidence indicating that the use of measurable residual disease (MRD) as a biomarker provides critical prognostic information and that…”
    Get full text
    Journal Article
  12. 12

    Decitabine Enhances Acute Myeloid Leukemia Cell Apoptosis through SH3BGRL Upregulation by Chen, Xiaomin, Liu, Fengqi, Rong, Dade, Xu, Limei, Tong, Xiuzhen, Wang, Haihe

    Published in Anti-cancer agents in medicinal chemistry (01-01-2022)
    “…SH3-domain-binding glutamic acid-rich protein-like protein (SH3BGRL) is downregulated in acute myeloid leukemia (AML). Clinically, DNA demethylating drug…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15

    Favorable Inductive Remission Rate of Decitabine Combined Chemotherapy on < 60-Years of Age MDS-like AML in the First Course by Liu, Fengqi, Tong, Xiuzhen, Zhou, Zhenhai, Zheng, Dong, Wang, Hehua, Liu, Junru, Huang, Beihui, Su, Chang, Zou, Waiyi, Xu, Duorong, Li, Juan

    Published in Blood (29-11-2018)
    “…Background: Acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) includes a history of myelodysplasia syndrome (MDS) and no MDS history (30% of…”
    Get full text
    Journal Article
  16. 16

    SH3BGRL as a novel prognostic biomarker is down-regulated in acute myeloid leukemia by Xu, Limei, Zhang, Mingming, Li, Hui, Guan, Wen, Liu, Bin, Liu, Fengqi, Wang, Hehua, Li, Juan, Yang, Shulan, Tong, Xiuzhen, Wang, Haihe

    Published in Leukemia & lymphoma (03-04-2018)
    “…Phosphatase PRL-3 expression is positively associated to acute myeloid leukemia (AML) progression and drug resistance. SH3-domain-binding glutamic acid-rich…”
    Get full text
    Journal Article
  17. 17

    Value of systemic PET/CT in the diagnosis and differential diagnosis of aplastic anemia by Chen, Meilan, Lu, Liyuan, Li, Juan, Zhang, Bin, Liu, Junru, Gu, Jingli, Zheng, Dong, Tong, Xiuzhen, Wang, Hehua

    Published in Oncology letters (01-09-2018)
    “…The aim of the present study was to investigate the value of systemic [ F]fluorodeoxyglucose positron emission tomography (PET)/computed tomography (CT) in the…”
    Get full text
    Journal Article
  18. 18

    Expression of the CD117 Antigen on Multiple Myeloma and Its Significance by Li, Juan, Luo, Shaokai, Zhang, Guocai, Hong, Wende, Tong, Xiuzhen

    Published in Blood (16-11-2004)
    “…BACKGROUND & OBJECTIVE: Leukocyte differentiation antigen CD117 is one of the targets that tyrosine kinase selective inhibitors work on. CD117, whether the…”
    Get full text
    Journal Article
  19. 19